SCHEMBL3132819

SCHEMBL3132819

CCn1nc(COCCN2CCCC2)cc1-c1ccc2c(c1)c1cc(-c3ccc(Cl)cc3Cl)c(=O)n(C)c1n2C

nearest known ligand 0.39

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ SIGMAR1 Q99720 4/20 0.37
▸ KCNH2 Q12809 1/20 0.37
▸ MARS1 P56192 1/20 0.37
▸ MCHR1 Q99705 7/20 0.36
▸ CYP3A4 P08684 1/20 0.36
▸ CYP2C19 P33261 1/20 0.36
▸ SLC16A3 O15427 1/20 0.34
▸ SLC16A1 P53985 1/20 0.34
▸ MCTS1 Q9ULC4 1/20 0.34
▸ GABRA1 P14867 1/20 0.34
▸ GABRG2 P18507 1/20 0.34
▸ GABRB3 P28472 1/20 0.34
▸ GABRA5 P31644 1/20 0.34
▸ HRH3 Q9Y5N1 2/20 0.33
▸ HTR2A P28223 1/20 0.32
▸ HTR2C P28335 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL1338677 0.99 SIGMAR1 (0.37) SIGMAR1KCNH2MARS1MCHR1CYP3A4
SCHEMBL1338017 0.89 GABRA1 (0.43) MARS1SLC16A3SLC16A1MCTS1GABRA1
SCHEMBL1339707 0.83 MARS1 (0.47) SIGMAR1MARS1GABRA1GABRG2GABRB3
SCHEMBL1339551 0.81 MCHR1 (0.37) KCNH2MCHR1CYP3A4CYP2C19HTR2A
SCHEMBL1339397 0.78 MARS1 (0.39) SIGMAR1MARS1GABRA1GABRG2GABRB3
SCHEMBL1338626 0.78 MARS1 (0.49) MARS1
SCHEMBL1339487 0.76 MCHR1 (0.41) MCHR1CYP3A4CYP2C19
SCHEMBL1339170 0.75 MARS1 (0.38) MARS1GABRA1GABRG2GABRB3GABRA5
SCHEMBL1339384 0.74 GABRA1 (0.36) SLC16A3SLC16A1MCTS1GABRA1GABRG2
SCHEMBL1337031 0.74 CNR1 (0.35) MARS1MCHR1CYP3A4CYP2C19GABRA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1940840-B1 6-HETEROARYLPYRIDOINDOLONE DERIVATIVES, THEIR PREPARATION AND THERAPEUTIC USE THEREOF SANOFI AVENTIS (FR) 2010-07-21 — — EP disclosed
Send feedback